% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • fizrwinnr11 fizrwinnr11 Nov 1, 2012 10:06 AM Flag

    Pfizer disappoints on revenues

    Adverse currency translations cost the company $699 million in Q3-12 as compared with FAVORABLE translations of $951 million in the year-ago quarter. In addition, the 2011 quarter contained good one-time Prevnar-13 revenues from a pediatric catch-up dose versus no such item in 2012.

    There are a lot of moving parts with this company and revenues aren't that easy to predict. It's heartening though that despite the revenue miss, the company still met earnings expectation and will be buying back $10B of stock next year.

    Sentiment: Buy

32.18-0.36(-1.11%)Oct 21 4:00 PMEDT